Overview
Disorder of oral mucous membrane refers to various inflammatory and non-inflammatory conditions affecting the oral mucosa, often drug-induced or related to systemic diseases. These conditions can manifest as ulcers, erythema, vesicles, or fixed drug eruptions, impacting patient comfort and quality of life 1946.Diagnosis
Management
Special Populations
Key Recommendations
References
1 Rui Y, Xin T, Chen Y, Xiang B, Chen C, Chen Z. Drug-induced cough risk: A pharmacovigilance study of FDA adverse event reporting system database. Respiratory medicine 2025. link 2 Sittiphan S, Lim A, Khurram H, Dureh N, Dittakan K. Epidemiology of reported serious adverse drug reactions due to anti-infectives using nationwide database of Thailand. PloS one 2025. link 3 Srinivasan A, Selvarajan S, Shivabasappa S, Arunmozhy S. A Retrospective Observational Study of Adverse Drug Reactions (ADR) Reported to ADR Monitoring Centre from 2010 to 2020. Current drug safety 2025. link 4 Pandit S, Soni D, Krishnamurthy B, Belhekar MN. Comparison of WHO-UMC and Naranjo Scales for Causality Assessment of Reported Adverse Drug Reactions. Journal of patient safety 2024. link 5 Wickham ME, McGrail KM, Law MR, Cragg A, Hohl CM. Re-Exposure to Culprit Medication Following Adverse Drug Event Diagnosis in Canadian Emergency Department Patients: A Cohort Study. Pharmacoepidemiology and drug safety 2024. link 6 Verdieck A, Ardman E, Defelice N. Generalized maculopapular rash and fever. The Journal of family practice 2023. link 7 Doherty AS, Boland F, Moriarty F, Fahey T, Wallace E. Adverse drug reactions and associated patient characteristics in older community-dwelling adults: a 6-year prospective cohort study. The British journal of general practice : the journal of the Royal College of General Practitioners 2023. link 8 Trillenberg P, Sprenger A, Machner B. Sensitivity and specificity in signal detection with the reporting odds ratio and the information component. Pharmacoepidemiology and drug safety 2023. link 9 Aung AK, Zubrinich CM, Goh MSY, Snyder B, Tang MJ, Khu CYL et al.. Development and application of Adverse drug reactions reports QUality Algorithm (AQUA-12) score: a single-centre quality improvement initiative. European journal of clinical pharmacology 2023. link 10 Sharif MJH, Farrukh MJ, Khan FU, Khan Q, Ahmed SS, Kousar R et al.. Exploring the factors and barriers of healthcare professionals in tertiary care hospitals toward pharmacovigilance: a multicenter study from Khyber Pakhtunkhwa, Pakistan. Current medical research and opinion 2022. link 11 Comfort SM, Donzanti B, Dorrell D, Dhar S, Eden C, Donaldson F. Comparison of the MOdified NARanjo Causality Scale (MONARCSi) for Individual Case Safety Reports vs. a Reference Standard. Drug safety 2022. link 12 Banerjee AK. Molecular Fingerprinting by Single Cell Clone Analysis in Adverse Drug Reaction (ADR) Assessment. Current drug safety 2022. link 13 Zazzara MB, Palmer K, Vetrano DL, Carfì A, Onder G. Adverse drug reactions in older adults: a narrative review of the literature. European geriatric medicine 2021. link 14 Murali M, Suppes SL, Feldman K, Goldman JL. Utilization of the Naranjo scale to evaluate adverse drug reactions at a free-standing children's hospital. PloS one 2021. link 15 Riera-Arnau J, Alvarado Aguirre LA, Garcia Doladé N, Vidal Guitart X, Figueras A, Cereza García G. Patients' contribution to drug safety in Catalonia: the interest of personal feelings on adverse drug reactions. European journal of clinical pharmacology 2021. link 16 Zhao Z, Shen J, Shen C, Zhu B, Sun J, Yu J et al.. An investigation of pharmacovigilance and reporting of adverse drug reactions in hospitals: a cross-sectional study in China. Current medical research and opinion 2021. link 17 Létinier L, Jouganous J, Benkebil M, Bel-Létoile A, Goehrs C, Singier A et al.. Artificial Intelligence for Unstructured Healthcare Data: Application to Coding of Patient Reporting of Adverse Drug Reactions. Clinical pharmacology and therapeutics 2021. link 18 Abu Esba LC, Al Mardawi G, AlJasser MI, Aljohani B, Abu Alburak A. Adverse Drug Reactions Spontaneously Reported at a Tertiary Care Hospital and Preventable Measures Implemented. Journal of clinical pharmacy and therapeutics 2021. link 19 Gupta S, Gupta S, Mahendra A, Yadav A. Multiple widespread fixed drug eruption caused by rabeprazole. Journal of postgraduate medicine 2020. link 20 Gosselin A, Chabut C, Duhamel A, Desjardins I, Lebel D, Bussières JF. Detection of serious adverse drug reactions using diagnostic codes in the International Statistical Classification of Diseases and Related Health Problems. Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique 2020. link 21 Dubrall D, Just KS, Schmid M, Stingl JC, Sachs B. Adverse drug reactions in older adults: a retrospective comparative analysis of spontaneous reports to the German Federal Institute for Drugs and Medical Devices. BMC pharmacology & toxicology 2020. link 22 Wong SX, Tham MY, Goh CL, Cheong HH, Chan SY. Spontaneous cutaneous adverse drug reaction reports-An analysis of a 10-year dataset in Singapore. Pharmacology research & perspectives 2019. link 23 Lima EDC, Matos GC, Vieira JML, Gonçalves ICDCR, Cabral LM, Turner MA. Suspected adverse drug reactions reported for Brazilian children: cross-sectional study. Jornal de pediatria 2019. link 24 Lemay J, Alsaleh FM, Al-Buresli L, Al-Mutairi M, Abahussain EA, Bayoud T. Reporting of Adverse Drug Reactions in Primary Care Settings in Kuwait: A Comparative Study of Physicians and Pharmacists. Medical principles and practice : international journal of the Kuwait University, Health Science Centre 2018. link 25 Aung AK, Tang MJ, Adler NR, de Menezes SL, Goh MSY, Tee HW et al.. Adverse Drug Reactions Reported by Healthcare Professionals: Reaction Characteristics and Time to Reporting. Journal of clinical pharmacology 2018. link 26 Singh P, Agrawal M, Hishikar R, Joshi U, Maheshwari B, Halwai A. Adverse drug reactions at adverse drug reaction monitoring center in Raipur: Analysis of spontaneous reports during 1 year. Indian journal of pharmacology 2017. link 27 Varallo FR, Planeta CS, Herdeiro MT, Mastroianni PC. Imputation of adverse drug reactions: Causality assessment in hospitals. PloS one 2017. link 28 Sabblah GT, Darko DM, Mogtari H, Härmark L, van Puijenbroek E. Patients' Perspectives on Adverse Drug Reaction Reporting in a Developing Country: A Case Study from Ghana. Drug safety 2017. link 29 Wolverton SE. Practice Gaps: Drug Reactions. Dermatologic clinics 2016. link 30 Chen L, Jiang L, Shen A, Wei W. Development of a quality instrument for assessing the spontaneous reports of ADR/ADE using Delphi method in China. European journal of clinical pharmacology 2016. link 31 Ampadu HH, Hoekman J, de Bruin ML, Pal SN, Olsson S, Sartori D et al.. Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®. Drug safety 2016. link 32 Wallis KA. No medicine is sometimes the best medicine. BMJ case reports 2015. link 33 Katusiime B, Semakula D, Lubinga SJ. Adverse drug reaction reporting among health care workers at Mulago National Referral and Teaching hospital in Uganda. African health sciences 2015. link 34 Star K, Watson S, Sandberg L, Johansson J, Edwards IR. Longitudinal medical records as a complement to routine drug safety signal analysis. Pharmacoepidemiology and drug safety 2015. link 35 Nogueira Guerra L, Herdeiro MT, Ribeiro-Vaz I, Clérigo MI, Rocha C, Araújo A et al.. Adverse drug reactions in children: a ten-year review of reporting to the Portuguese Pharmacovigilance System. Expert opinion on drug safety 2015. link 36 Cederholm S, Hill G, Asiimwe A, Bate A, Bhayat F, Persson Brobert G et al.. Structured assessment for prospective identification of safety signals in electronic medical records: evaluation in the health improvement network. Drug safety 2015. link 37 Newe A, Wimmer S, Neubert A, Becker L, Prokosch HU, Beckmann MW et al.. Towards a Computable Data Corpus of Temporal Correlations between Drug Administration and Lab Value Changes. PloS one 2015. link 38 Iammatteo M, Blumenthal KG, Saff R, Long AA, Banerji A. Safety and outcomes of test doses for the evaluation of adverse drug reactions: a 5-year retrospective review. The journal of allergy and clinical immunology. In practice 2014. link 39 Belhekar MN, Taur SR, Munshi RP. A study of agreement between the Naranjo algorithm and WHO-UMC criteria for causality assessment of adverse drug reactions. Indian journal of pharmacology 2014. link 40 Afifi S, Maharloui N, Peymani P, Namazi S, Gharaei AG, Jahani P et al.. Adverse drug reactions reporting: pharmacists' knowledge, attitude and practice in Shiraz, Iran. The International journal of risk & safety in medicine 2014. link 41 Tyrell T, Gick J. Recent onset of rash, dehydration, and nonbloody diarrhea in an elderly man. The Journal of family practice 2013. link 42 Miguel A, Bernardo Marques, Freitas A, Lopes F, Azevedo L, Pereira AC. Detection of adverse drug reactions using hospital databases-a nationwide study in Portugal. Pharmacoepidemiology and drug safety 2013. link 43 Sanghavi DR, Dhande PP, Pandit VA. Perception of pharmacovigilance among doctors in a tertiary care hospital: influence of an interventional lecture. The International journal of risk & safety in medicine 2013. link 44 Lobo MG, Pinheiro SM, Castro JG, Momenté VG, Pranchevicius MC. Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil. BMC pharmacology & toxicology 2013. link 45 Théophile H, André M, Miremont-Salamé G, Arimone Y, Bégaud B. Comparison of three methods (an updated logistic probabilistic method, the Naranjo and Liverpool algorithms) for the evaluation of routine pharmacovigilance case reports using consensual expert judgement as reference. Drug safety 2013. link 46 Özkaya E. Oral mucosal fixed drug eruption: characteristics and differential diagnosis. Journal of the American Academy of Dermatology 2013. link 47 Aagaard L, Strandell J, Melskens L, Petersen PS, Holme Hansen E. Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™. Drug safety 2012. link 48 Oosterhuis I, van Hunsel FP, van Puijenbroek EP. Expectations for feedback in adverse drug reporting by healthcare professionals in the Netherlands. Drug safety 2012. link 49 Lee JH, Park KH, Moon HJ, Lee YW, Park JW, Hong CS. Spontaneous reporting of adverse drug reactions through electronic submission from regional society healthcare professionals in Korea. Yonsei medical journal 2012. link 50 Vodovar D, LeBeller C, Mégarbane B, Lillo-Le-Louet A, Hanslik T. Drug Fever: a descriptive cohort study from the French national pharmacovigilance database. Drug safety 2012. link 51 Conforti A, Opri S, D'Incau P, Sottosanti L, Moretti U, Ferrazin F et al.. Adverse drug reaction reporting by nurses: analysis of Italian pharmacovigilance database. Pharmacoepidemiology and drug safety 2012. link 52 Aldea A, García Sánchez-Colomer M, Fernández Quintana E, García Sáiz M. Paediatric adverse drug reactions reported to the Spanish Pharmacovigilance System from 2004 to 2009. European journal of clinical pharmacology 2012. link 53 van Oijen B, Pleunis M, Erdkamp F, Prevoo R, van der Kuy H. Toxic dermatitis in patients treated with Taxotere® (docetaxel): three case reports. International journal of clinical pharmacology and therapeutics 2011. link 54 Ferreira TS, Mangilli LD, Sassi FC, Fortunato-Tavares T, Limongi SC, Andrade CR. Speech and myofunctional exercise physiology: a critical review of the literature. Jornal da Sociedade Brasileira de Fonoaudiologia 2011. link 55 Gallagher RM, Kirkham JJ, Mason JR, Bird KA, Williamson PR, Nunn AJ et al.. Development and inter-rater reliability of the Liverpool adverse drug reaction causality assessment tool. PloS one 2011. link 56 González-Rubio F, Calderón-Larrañaga A, Poblador-Plou B, Navarro-Pemán C, López-Cabañas A, Prados-Torres A. Underreporting of recognized adverse drug reactions by primary care physicians: an exploratory study. Pharmacoepidemiology and drug safety 2011. link 57 Shrivastava M, Uchit G, Chakravarti A, Joshi G, Mahatme M, Chaudhari H. Adverse drug reactions reported in Indira Gandhi Government Medical College and Hospital, Nagpur. The Journal of the Association of Physicians of India 2011. link 58 Lee HY, Tay LK, Thirumoorthy T, Pang SM. Cutaneous adverse drug reactions in hospitalised patients. Singapore medical journal 2010. link 59 Arencibia ZB, Sotomayor DN, Mollinedo NC, Choonara I, Manzano EF, Leyva AL. Adverse drug reactions in children in Camagüey Province, Cuba. Archives of disease in childhood 2010. link 60 Maignen F, Hauben M, Tsintis P. Modelling the time to onset of adverse reactions with parametric survival distributions: a potential approach to signal detection and evaluation. Drug safety 2010. link 61 Oshikoya KA, Senbanjo IO, Njokanma OF. Parental reporting of suspected adverse drug reactions in children in Lagos, Nigeria. Archives of disease in childhood 2009. link 62 Passier A, ten Napel M, van Grootheest K, van Puijenbroek E. Reporting of adverse drug reactions by general practitioners: a questionnaire-based study in the Netherlands. Drug safety 2009. link 63 van Puijenbroek E, Conemans J, van Grootheest K. Spontaneous ADR reports as a trigger for pharmacogenetic research: a prospective observational study in the Netherlands. Drug safety 2009. link 64 Cudny ME, Graham AS. Adverse-drug-event data provided by pharmaceutical companies. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2008. link 65 Segal AR, Doherty KM, Leggott J, Zlotoff B. Cutaneous reactions to drugs in children. Pediatrics 2007. link 66 Jha N, Bajracharya O, Namgyal T. Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley. Kathmandu University medical journal (KUMJ) 2007. link 67 Uetrecht J. Idiosyncratic drug reactions: current understanding. Annual review of pharmacology and toxicology 2007. link 68 Lawrentschuk N, Pan D, Troy A. Fixed drug eruption of the penis secondary to sulfamethoxazole-trimethoprim. TheScientificWorldJournal 2006. link 69 Arimone Y, Bégaud B, Miremont-Salamé G, Fourrier-Réglat A, Molimard M, Moore N et al.. A new method for assessing drug causation provided agreement with experts' judgment. Journal of clinical epidemiology 2006. link 70 Le J, Nguyen T, Law AV, Hodding J. Adverse drug reactions among children over a 10-year period. Pediatrics 2006. link 71 Polimeni G, Salvo F, Cutroneo P, Morreale I, Patrizio Caputi A. Adverse reactions induced by NSAIDs and antibacterials: analysis of spontaneous reports from the Sicilian regional database. Drug safety 2006. link 72 Peyrière H, Dereure O, Breton H, Demoly P, Cociglio M, Blayac JP et al.. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?. The British journal of dermatology 2006. link 73 Frattarelli DA. Adverse drug reactions and avalanches: life at the edge of chaos. Journal of clinical pharmacology 2005. link 74 Hauben M, Reich L. Endotoxin-like reactions with intravenous gentamicin: results from pharmacovigilance tools under investigation. Infection control and hospital epidemiology 2005. link 75 Kane-Gill SL, Kirisci L, Pathak DS. Are the Naranjo criteria reliable and valid for determination of adverse drug reactions in the intensive care unit?. The Annals of pharmacotherapy 2005. link 76 Tisonová J, Szalayová A, Kriska M, Gibala P, Foltán V. Factors influencing the spontaneous reporting of adverse drug reactions--the experience of the Slovak Republic. Pharmacoepidemiology and drug safety 2004. link 77 Schirm E, Tobi H, van Puijenbroek EP, Monster-Simons MH, de Jong-van den Berg LT. Reported adverse drug reactions and their determinants in Dutch children outside the hospital. Pharmacoepidemiology and drug safety 2004. link 78 Grim SA, Romanelli F, Jennings PR, Ofotokun I. Late-onset drug fever associated with minocycline: case report and review of the literature. Pharmacotherapy 2003. link 79 Wu WK, Pantaleo N. Evaluation of outpatient adverse drug reactions leading to hospitalization. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2003. link 80 Jarernsiripornkul N, Krska J, Capps PA, Richards RM, Lee A. Patient reporting of potential adverse drug reactions: a methodological study. British journal of clinical pharmacology 2002. link 81 Sharma VK, Sethuraman G, Kumar B. Cutaneous adverse drug reactions: clinical pattern and causative agents--a 6 year series from Chandigarh, India. Journal of postgraduate medicine 2001. link 82 Morales-Olivas FJ, Martínez-Mir I, Ferrer JM, Rubio E, Palop V. Adverse drug reactions in children reported by means of the yellow card in Spain. Journal of clinical epidemiology 2000. link00190-6) 83 McNeil JJ, Grabsch EA, McDonald MM. Postmarketing surveillance: strengths and limitations. The flucloxacillin-dicloxacillin story. The Medical journal of Australia 1999. link 84 Moore N, Lecointre D, Noblet C, Mabille M. Frequency and cost of serious adverse drug reactions in a department of general medicine. British journal of clinical pharmacology 1998. link 85 MacNeil M, Haase DA, Tremaine R, Marrie TJ. Fever, lymphadenopathy, eosinophilia, lymphocytosis, hepatitis, and dermatitis: a severe adverse reaction to minocycline. Journal of the American Academy of Dermatology 1997. link80414-8) 86 Knowles S, Shapiro L, Shear NH. Serious dermatologic reactions in children. Current opinion in pediatrics 1997. link 87 Björnsson E, Lindberg J, Olsson R. Liver reactions to oral low-dose tetracyclines. Scandinavian journal of gastroenterology 1997. link 88 Hunziker T, Künzi UP, Braunschweig S, Zehnder D, Hoigné R. Comprehensive hospital drug monitoring (CHDM): adverse skin reactions, a 20-year survey. Allergy 1997. link 89 Mochida K, Teramae H, Hamada T. Fixed drug eruption due to colchicine. Dermatology (Basel, Switzerland) 1996. link 90 Stein BE. Avoiding drug reactions: seven steps to writing safe prescriptions. Geriatrics 1994. link 91 Maddison JE. Adverse drug reactions: report of the Australian Veterinary Association Adverse Drug Reaction Subcommittee, 1993. Australian veterinary journal 1994. link 92 . Cutaneous reactions to analgesic-antipyretics and nonsteroidal anti-inflammatory drugs. Analysis of reports to the spontaneous reporting system of the Gruppo Italiano Studi Epidemiologici in Dermatologia. Dermatology (Basel, Switzerland) 1993. link 93 Burkhardt ME, Ripepe SD. Reporting adverse drug reactions is everyone's business: an adverse drug reaction reporting program that works. Topics in hospital pharmacy management 1992. link 94 Ives TJ, Bentz EJ, Gwyther RE. Dermatologic adverse drug reactions in a family medicine setting. Archives of family medicine 1992. link 95 Meyboom RH. Adverse reaction to drugs in children, experiences with "spontaneous monitoring" in The Netherlands. Bratislavske lekarske listy 1991. link 96 Henderson CA, Shamy HK. Atenolol-induced pseudolymphoma. Clinical and experimental dermatology 1990. link 97 Bridges AJ, Graziano FM, Calhoun W, Reizner GT. Hyperpigmentation, neutrophilic alveolitis, and erythema nodosum resulting from minocycline. Journal of the American Academy of Dermatology 1990. link70135-5) 98 Payne FE, Giesecke TF. Multiple system reaction to trimethoprim-sulfamethoxazole. Southern medical journal 1987. link 99 Frazer M, Gault R. Death as a result of an adverse reaction from nalidixic acid. Journal of forensic sciences 1986. link 100 Tóth Kása I, Dobozy A. Drug fever caused by PUVA treatment. Acta dermato-venereologica 1985. link